Friday, May 10, 2013Inktank Gets $13.4M For Cloud Storage TechnologyLos Angeles-based Inktank, the developer of the open source, massively parallel, distributed file system Ceph, has added $13.4M into its coffers, according to a regulatory filing by the firm Friday. The filing says the funding--in the form of a debt round--came from four investors. Details on the investment have not yet been announced by the company. Inktank, which is a spinout of Dreamhost, has been developing the Ceph distributed file system for Linux, which is used to deliver high performance (More info...)
posted on Friday, May 10, 2013 (More)(Full story)
Tealium Hires Chief Revenue OffierSan Diego-based Tealium said this week that it has added a Chief Revenue Officer to help support the company's rapid growth. The firm said it named Brian Blond as CRO, to oversee its growth strategy and all direct and indirect distribution channels. Blond joins the firm from Vitrue, and also had served at Moxie Software and BladeLogic. Tealium is a venture backed developer of tag management software, used by enterprise to manage the tags on their websites. The firm is backed by Tenaya Capital, B (More info...)
posted on Friday, May 10, 2013(Full story)
Triton Digital Names CTOLos Angeles-based Triton Digital, the Oaktree Capital-backed provider of digital advertising services to the traditional and online radio market, said today that it has named Jean-Francois ("Jeff") Gadoury as its Chief Technology Officer. Gadoury has been Chief Technology Officer of the company's streaming products for the last six years. Prior to that, he was at Cesart International/Bell Canada, and also has served at Tata Communications, Atlas Telecom Mobile, and CESCOM. Triton Digital said th (More info...)
posted on Friday, May 10, 2013(Full story)
How The Promise Of Social Media Advertising Is Measuring Up For Adly
Four years ago, Los Angeles-based Adly (www.adly.com) launched to much fanfare as one of the first local startups to tie into the brand-new, Twitter micro messaging platform. We caught up with CEO Walter Delph to hear how the promise of social media advertising has measured up to reality, and what that means for brands and marketers today trying to leverage the new reality of social conversations.
What is Ad.ly's business now?
Walter Delph: Social networks like Twitter and YouTube have (More info...)
posted on Friday, May 10, 2013(Full story)
uParts Gets $2M To Revolutionize Auto Parts Business
uParts has a mission: revolutionize the auto parts procurement business. The Irvine-based startup also now has $2M in the bank to help it with that goal, announcing this morning that it has raised a Series A funding from GRP Partners, Fraser McCombs Capital, along with others. uParts said it is developing electronic parts procurement systems for the collision repair industry, which streamlines the identification, location, and procurement of auto parts.
uParts said that auto repair facilit (More info...)
posted on Friday, May 10, 2013 (More)(Full story)
HitFix Launches Comedy ChannelLos Angeles-based entertainment news provider HitFix said Thursday that it has launched a new comedy channel on the site. HitFix said its RIOT comedy channel will provide original content, video, and more covering the "lighter side of entertainment and celebrity." HitFix was co-founded by Jennifer Sargenta nd Gregory Ellwood, and offers up entertainment news and video around the movie, music, TV, and other areas. HitFix said the new channel was inspired by popular sites like Funny or Die, Colleg (More info...)
posted on Friday, May 10, 2013(Full story)
Amgen In Chinese Joint VentureThousand Oaks-based biotech giant Amgen said Thursday that it is in a joint venture with Chinese company Zhejiang Beta Pharma, to commercialize the firm's Vectibix (panitumumab) product in the Chinese market. Financial arrangements of the joint venture were not announced. The two said the new JV will be named Amgen-Beta Pharmaceuticals Co., and that Zhejiang Beta Pharma will own 51 percent of the company, with Amgen owning the remaining 49 percent. Amgen's Vectibix is used to treat colorectal c (More info...)
posted on Friday, May 10, 2013(Full story)
Isis Pharmaceuticals Gets $3.5M From Biogen IdecCarlsbad-based biopharmaceuticals developer Isis Pharmaceuticals reported Thursday that it has received $3.5M in a milestone payment, from Biogen Idec. The company said the payment was received as part of a Phase 2 study milestone of a treatment for infants with spinal muscular atrophy (SMA). Isis is collaborating with Biogen Idec to develop and potentially commercialize the compound. The two had inked a deal in January of 2012 for the development and licensing of the drug.
posted on Friday, May 10, 2013(Full story)